Case Report: Leprosy and Tuberculosis Co-Infection: Clinical and Immunological Report of Two Cases and Review of the Literature
Carregando...
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC TROP MED & HYGIENE
Autores
Citação
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, v.88, n.2, p.236-240, 2013
Resumo
A review of the records of patients seen between 2004 and 2011 at the Dermatology Clinic of the Sao Paulo University Medical School showed that only two leprosy patients had been co-infected with tuberculosis (TB). One patient showed a type 1 leprosy reaction during the first 3 months of treatment of pleural TB and in the other patient, pulmonary TB was diagnosed during the first 3 months of treatment of a type 1 leprosy reaction. Both patients showed normal cellular immune response tests, including those of the interferon-gamma (IFN-gamma)/interleukin 12 (IL-12) axis. Although both mycobacterial infections are endemic in developing countries like Brazil, the co-infection has hardly been reported in the last decade. There is no suitable explanation for this observation. The reports on the interaction between the two mycobacteria are highly speculative: some studies suggest that leprosy, especially the anergic form, would predispose to TB, whereas other investigations suggested an antagonism between the two diseases.
Palavras-chave
Referências
- Agarwal DK, 2000, NEPHROL DIAL TRANSPL, V15, P1720, DOI 10.1093/ndt/15.10.1720
- BEYT BE, 1981, MEDICINE, V60, P95
- CARTEL JL, 1992, LEPROSY REV, V63, P211
- Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851
- CHAUSSINAND R., 1948, INTERNAT JOUR LEPROSY, V16, P431
- Delobel P, 2003, CLIN INFECT DIS, V37, P628, DOI 10.1086/376632
- Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966
- GATNER EMS, 1980, LEPROSY REV, V51, P5
- GLAZIOU P, 1993, INT J LEPROSY, V61, P199
- GRAY H H, 1952, Int J Lepr, V20, P467
- INAMADAR AC, 1994, LEPROSY REV, V65, P282
- International Institute for Population Sciences (IIPS), 2007, MACR NAT FAM HLTH SU, V2
- KAKLAMANI E, 1991, LANCET, V337, P304, DOI 10.1016/0140-6736(91)90917-E
- KAUR S, 1979, INT J LEPROSY, V47, P18
- Kumar B, 1982, Lepr India, V54, P671
- Lazaro FP, 2010, J INFECT DIS, V201, P1598, DOI 10.1086/652007
- Lee MN, 2003, J AM ACAD DERMATOL, V49, P755
- Lietman T, 1997, AM J PUBLIC HEALTH, V87, P1923, DOI 10.2105/AJPH.87.12.1923
- Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7
- Ministerio da Saude, 2011, SIN SVS MS
- NAAFS B, 1978, LEPROSY REV, V49, P153
- Nigam P, 1979, Lepr India, V51, P65
- Ohara N, 2000, VACCINE, V18, P1294, DOI 10.1016/S0264-410X(99)00420-X
- Penna MLF, 2008, REV SOC BRAS MED TRO, V41, P6, DOI 10.1590/S0037-86822008000700003
- Prasad Rajendra, 2010, Lung India, V27, P19, DOI 10.4103/0970-2113.59263
- Premanath M, 1976, J Indian Med Assoc, V67, P143
- Fine PEM, 1996, LANCET, V348, P17
- Quagliato Júnior Reynaldo, 2007, J Bras Pneumol, V33, P295, DOI 10.1590/S1806-37132007000300011
- Rao GR, 2011, INDIAN J DERMATOL VE, V77, DOI 10.4103/0378-6323.74997
- Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
- SAHA K, 1989, EUR J CLIN NUTR, V43, P117
- Scollard DM, 2011, J AM ACAD DERMATOL, V64, P593, DOI 10.1016/j.jaad.2009.10.004
- Sreeramareddy CT, 2007, J MED CASE REPORTS, V1, P1
- STANLEY SJ, 1981, J HYG-CAMBRIDGE, V87, P233
- Styblo K, 1980, Adv Tuberc Res, V20, P1
- Trindade MAB, 2005, LEPROSY REV, V76, P162
- Viel B, 1960, INT J LEPROSY, V28, P483
- World Health Organization, 2011, WKLY EPIDEMIOL REC, V86, P389